NCT00003443View on ClinicalTrials.gov

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1998

Primary Completion Date

May 31, 2001

Study Completion Date

May 31, 2001

Conditions
Head and Neck Cancer
Interventions
DRUG

bryostatin 1

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003443 - Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | Biotech Hunter | Biotech Hunter